News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
778,529 Results
Type
Article (63642)
Company Profile (343)
Press Release (714544)
Multimedia
Podcasts (110)
Webinars (14)
Section
Business (220147)
Career Advice (2915)
Deals (38254)
Drug Delivery (129)
Drug Development (88397)
Employer Resources (183)
FDA (17815)
Job Trends (16249)
News (377157)
Policy (38162)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (5)
2024 BioForest Standard (1)
2024 BioMidwest Digital (11)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (8)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2912)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (91)
Alliances (54474)
ALS (98)
Alzheimer's disease (1490)
Antibody-drug conjugate (ADC) (154)
Approvals (17780)
Artificial intelligence (291)
Autoimmune disease (28)
Automation (16)
Bankruptcy (394)
Best Places to Work (12224)
BIOSECURE Act (22)
Biosimilars (118)
Biotechnology (235)
Bladder cancer (72)
Brain cancer (31)
Breast cancer (291)
Cancer (2301)
Cardiovascular disease (200)
Career advice (2442)
Career pathing (34)
CAR-T (166)
Cell therapy (453)
Cervical cancer (21)
Clinical research (71437)
Collaboration (881)
Compensation (538)
Complete response letters (30)
COVID-19 (2853)
CRISPR (45)
C-suite (251)
Cystic fibrosis (107)
Data (2150)
Decentralized trials (2)
Denatured (33)
Depression (53)
Diabetes (288)
Diagnostics (6829)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (46)
Drug discovery (141)
Drug pricing (126)
Drug shortages (33)
Duchenne muscular dystrophy (100)
Earnings (90700)
Editorial (43)
Employer branding (22)
Employer resources (157)
Events (121364)
Executive appointments (746)
FDA (19087)
Featured Employer (55)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (790)
Gene editing (113)
Generative AI (25)
Gene therapy (331)
GLP-1 (841)
Government (4940)
Grass and pollen (6)
Guidances (52)
Healthcare (20111)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (143)
Indications (29)
Infectious disease (3014)
Inflammatory bowel disease (149)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (97)
Interviews (531)
IPO (17356)
IRA (51)
Job creations (4466)
Job search strategy (2040)
Kidney cancer (11)
Labor market (38)
Layoffs (539)
Leadership (22)
Legal (9611)
Liver cancer (77)
Lung cancer (335)
Lymphoma (152)
Machine learning (6)
Management (63)
Manufacturing (335)
MASH (73)
Medical device (14245)
Medtech (14250)
Mergers & acquisitions (21430)
Metabolic disorders (769)
Multiple sclerosis (83)
NASH (23)
Neurodegenerative disease (108)
Neuropsychiatric disorders (34)
Neuroscience (2072)
NextGen: Class of 2025 (7146)
Non-profit (4847)
Northern California (2652)
Now hiring (40)
Obesity (419)
Opinion (269)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (83)
Parkinson's disease (159)
Partnered (21)
Patents (243)
Patient recruitment (108)
Peanut (51)
People (62132)
Pharmaceutical (75)
Pharmacy benefit managers (21)
Phase I (22106)
Phase II (31099)
Phase III (23437)
Pipeline (1189)
Policy (166)
Postmarket research (3289)
Preclinical (9598)
Press Release (70)
Prostate cancer (105)
Psychedelics (38)
Radiopharmaceuticals (266)
Rare diseases (421)
Real estate (6728)
Recruiting (69)
Regulatory (25870)
Reports (47)
Research institute (2604)
Resumes & cover letters (474)
Rett syndrome (4)
RNA editing (4)
RSV (50)
Schizophrenia (78)
Series A (139)
Series B (88)
Service/supplier (17)
Sickle cell disease (58)
Southern California (2300)
Special edition (18)
Spinal muscular atrophy (163)
Sponsored (34)
Startups (4008)
State (2)
Stomach cancer (16)
Supply chain (73)
Tariffs (38)
The Weekly (75)
United States (23478)
Vaccines (791)
Venture capitalists (44)
Weight loss (300)
Women's health (38)
Worklife (19)
Date
Today (157)
Last 7 days (643)
Last 30 days (2602)
Last 365 days (34714)
2025 (10514)
2024 (37199)
2023 (42084)
2022 (53467)
2021 (58100)
2020 (56779)
2019 (49787)
2018 (37758)
2017 (35699)
2016 (36101)
2015 (41876)
2014 (36206)
2013 (31441)
2012 (33619)
2011 (34143)
2010 (32867)
Location
Africa (1008)
Alabama (59)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (45159)
Australia (7532)
California (6132)
Canada (1994)
China (539)
Colorado (274)
Connecticut (288)
Delaware (146)
Europe (101222)
Florida (904)
Georgia (207)
Hawaii (1)
Idaho (61)
Illinois (570)
India (29)
Indiana (321)
Iowa (10)
Japan (163)
Kansas (105)
Kentucky (25)
Louisiana (12)
Maine (70)
Maryland (923)
Massachusetts (4622)
Michigan (227)
Minnesota (406)
Mississippi (2)
Missouri (89)
Montana (29)
Nebraska (26)
Nevada (60)
New Hampshire (65)
New Jersey (1749)
New Mexico (30)
New York (1747)
North Carolina (1061)
North Dakota (8)
Northern California (2652)
Ohio (211)
Oklahoma (14)
Oregon (40)
Pennsylvania (1362)
Puerto Rico (12)
Rhode Island (32)
South America (1387)
South Carolina (23)
South Dakota (1)
Southern California (2300)
Tennessee (103)
Texas (907)
Utah (184)
Virginia (149)
Washington D.C. (67)
Washington State (567)
West Virginia (3)
Wisconsin (61)
778,529 Results for "u s drug testing inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Alzheimer’s disease
EU Rejects Lilly’s Alzheimer’s Drug Kisunla, Following Same Path as Rival Leqembi
The European Union’s CHMP said that the benefits of the drug, already approved in the U.S., do not outweigh the risk of potentially fatal brain swelling and bleeding.
March 28, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Equillium Announces Feedback from the U.S. Food and Drug Administration
April 24, 2025
·
5 min read
Press Releases
Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
March 13, 2025
·
6 min read
Press Releases
U.S. FDA Approves Second Drug Product Manufacturing Facility for ADSTILADRIN® (nadofaragene firadenovec-vncg)
April 25, 2025
·
10 min read
Press Releases
Applied DNA’s LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA
April 22, 2025
·
4 min read
Press Releases
Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
April 14, 2025
·
5 min read
Press Releases
U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
April 17, 2025
·
17 min read
Press Releases
Tenpoint Therapeutics Ltd. Submits New Drug Application to U.S. FDA for BRIMOCHOL™ PF for the Treatment of Presbyopia
April 8, 2025
·
5 min read
Business
Five Biggest Drug Face-Offs in Pharma History
Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of rivalry that includes blockbuster drugs Keytruda, Humira and Eliquis.
April 9, 2025
·
9 min read
·
Tristan Manalac
Collaboration
Cassava’s Stock Rises After Licensing Seizure Rights for Embattled Drug Simufilam
The licensing deal follows years of controversy for Cassava, as well as the high-profile late-stage failure of its Alzheimer’s disease drug simufilam.
February 28, 2025
·
2 min read
·
Tristan Manalac
1 of 77,853
Next
